Su-Hsin Chang

Medicine & Life Sciences

1. African Americans 28%
2. Allografts 39%
3. Bariatric Surgery 63%
4. Body Mass Index 74%
5. Breast Neoplasms 39%
6. Cohort Studies 25%
7. Confidence Intervals 51%
8. Cost-Benefit Analysis 95%
9. Costs and Cost Analysis 70%
10. Decision Support Techniques 34%
11. Diethylhexyl Phthalate 42%
12. Early Detection of Cancer 29%
13. Economics 26%
14. European Continental Ancestry Group 31%
15. Gastric Bypass 43%
16. Health Expenditures 51%
17. Health Status 24%
18. Health Surveys 41%
19. Hepatitis C 28%
20. Hysterectomy 27%
21. Income 34%
22. Interviews 28%
23. Kidney 79%
24. Kidney Transplantation 57%
25. Life Expectancy 23%
26. Liver Transplantation 50%
27. Medication Adherence 30%
28. Meta-Analysis 24%
29. Metformin 44%
30. mono-(2-ethylhexyl)phthalate 39%
31. Monoclonal Gammopathy of Undetermined Significance 39%
32. Mortality 51%
33. Multiple Myeloma 54%
34. Non-Small Cell Lung Carcinoma 49%
35. Nutrition Surveys 31%
36. Obesity 80%
37. Odds Ratio 26%
38. Pancreas 46%
39. Pancreas Transplantation 42%
40. phthalic acid 25%
41. Population 26%
42. Quality-Adjusted Life Years 49%
43. Robotics 28%
44. Survival 90%
45. Systematic Reviews 40%
46. Tissue and Organ Procurement 33%
47. Tissue Donors 53%
48. Transplants 100%
49. Veterans 71%
50. Weight Loss 33%